New Coronavirus Wave Hits India: What We Know
India reported over 1,000 active COVID-19 cases on May 26, 2025. The sudden spike has raised concerns. Health officials are monitoring the situation closely.
New variants and waning immunity are key factors. Here’s a breakdown of the recent developments.
Recent Case Surge
India recorded 1,009 active COVID-19 cases on May 26, 2025. This is a sharp rise from 257 cases on May 19. Kerala, Maharashtra, and Delhi are the hardest hit.
Kerala alone reported 430 active cases. Maharashtra has 209 cases, while Delhi noted 104. Over 700 new cases emerged in the past week. The surge aligns with rising infections in Asia, including Singapore and Hong Kong.
Background of the Spike
The increase follows a period of low case numbers. COVID-19 remains endemic globally. Waning immunity from prior infections and vaccinations is a factor.
Increased social mixing and relaxed preventive measures also contribute. Seasonal changes may amplify transmission. The rise mirrors trends in Southeast Asia, where variants are spreading. India’s health system is on alert but not in panic mode.
New Variants Detected
New variants NB.1.8.1 and LF.7 are circulating. These are descendants of the JN.1 variant, part of the Omicron family. JN.1, a subvariant of BA.2.86, was first identified in Luxembourg in 2023.
It’s more transmissible due to spike protein mutations. NB.1.8.1 was detected in Tamil Nadu in April. LF.7 was found in Gujarat in May. The World Health Organization (WHO) lists both as Variants Under Monitoring, not Variants of Concern.
Symptoms: Normal Fever or More?
Symptoms of these variants resemble a mild cold or flu. Common signs include sore throat, mild cough, fatigue, and fever. JN.1 often causes persistent low-grade fever (37.6°C–38.1°C). Gastrointestinal issues like nausea and diarrhea are more frequent with JN.1. Loss of taste or smell is rare, unlike earlier variants. Most cases are mild, with no major hospitalization spikes. Health experts advise testing for fever to confirm infection.
Official Statements
The Union Health Ministry urges calm and caution. The Indian Council of Medical Research (ICMR) says symptoms are mild. No new variant-specific drugs are needed yet. Hospitals are prepared, with no severe illness spikes reported. Dr. Singh from ICMR noted patients show fever, cough, and cold. The ministry is monitoring variants closely. States are advised to maintain hygiene and vigilance.
Public Health Response
Health authorities are scaling up testing. Genomic sequencing is ongoing to track variants. Advisories recommend masks for the elderly and those with comorbidities. Vaccination boosters are encouraged to prevent severe outcomes. Hospitals in affected states are ready for potential surges. The public is urged to avoid panic but stay cautious. Most cases are managed at home, with minimal hospitalizations.
New variants NB.1.8.1 and LF.7
The recent spike in COVID-19 cases in India, crossing 1,000 on May 26, 2025, is driven by new variants NB.1.8.1 and LF.7, alongside waning immunity. Symptoms are mild, often mimicking a normal fever or cold, with low-grade fever and gastrointestinal issues noted in JN.1 cases. Kerala, Maharashtra, and Delhi lead in case numbers, but no severe illness surge is reported.
Health officials emphasize preparedness, urging hygiene and caution without alarm. The WHO classifies the variants as low-risk globally. India’s health system remains vigilant, with testing and vaccinations as key defenses.
Trump’s $21M USAID Claim for India Elections Never Existed 
Did India Strike Pakistan’s Nuclear Hub Kirana Hills? 
What’s Happening in Iran: India Urges Citizens to Exit 
Why Did Bangladesh Choose Mangoes for PM Modi? 
Principal Arrested for ‘Period Check’ in Thane School 
How an Indian Air Force Jaguar Crashed in Rajasthan’s Churu